Comments

Compass Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Compass Therapeutics (CMPX) operate in?

Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CMPXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.99

-0.11-5.24%

At close: -

$1.97

-0.02-1.01%

After Hours: 7:39 PM EDT

Compass Therapeutics (CMPX) Forecast

News Earnings Compass Therapeutics (CMPX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compass Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CMPX | Benzinga

Explore Compass Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CMPX.

Open	$2.15
Close	$1.99
Volume / Avg.	691.50K / 1.53M
Day Range	$1.97 - $2.17
52 Wk Range	0.77 - 4.08
Market Cap	$271.05M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.73%
Days to Cover	5.86

Recent News

This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Top 3 High-Momentum Companies Analysts Are Still Bullish On

The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline.

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.15
Close	$1.99
Volume / Avg.	691.50K / 1.53M
Day Range	$1.97 - $2.17
52 Wk Range	0.77 - 4.08
Market Cap	$271.05M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.73%
Days to Cover	5.86

About Compass Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary ant...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Compass Therapeutics (CMPX) stock?

You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.

View our list of the best stock brokerages

Who are Compass Therapeutics (CMPX) competitors?

Other companies in Compass Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).

What is the forecast, or price target, for Compass Therapeutics (CMPX) stock?

Compass Therapeutics has a consensus price target of $11.39.

What is the current price for Compass Therapeutics (CMPX)?

The stock price for Compass Therapeutics (NASDAQ: CMPX) is $1.97 last updated March 28, 2025 at 7:39 PM EDT.

Does Compass Therapeutics (CMPX) pay a dividend?

There are no upcoming dividends for Compass Therapeutics.

When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?

Compass Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Compass Therapeutics (CMPX) going to split?

There is no upcoming split for Compass Therapeutics.

What sector and industry does Compass Therapeutics (CMPX) operate in?

Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.